SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023045
Filing Date
2022-06-13
Accepted
2022-06-13 07:32:20
Documents
15
Period of Report
2022-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20220608.htm   iXBRL 8-K 40669
2 EX-10.1 sndx-ex101_16.htm EX-10.1 193873
3 EX-99.1 sndx-ex991_15.htm EX-99.1 12814
4 GRAPHIC g4aleoqnoabd000001.jpg GRAPHIC 13868
  Complete submission text file 0001564590-22-023045.txt   437774

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sndx-20220608.xsd EX-101.SCH 5581
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20220608_lab.xml EX-101.LAB 20077
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20220608_pre.xml EX-101.PRE 11931
9 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20220608_htm.xml XML 3661
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 221010705
SIC: 2834 Pharmaceutical Preparations